Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade

Ursolic acid (UA), a pentacyclic triterpenoid extracted from various plants, inhibits cell growth, metastasis, and tumorigenesis in various cancers. Chemotherapy resistance and the side effects of paclitaxel (PTX), a traditional chemotherapy reagent, have limited the curative effect of PTX in esopha...

Full description

Bibliographic Details
Main Authors: Ruo Yu Meng, Hua Jin, Thi Van Nguyen, Ok-Hee Chai, Byung-Hyun Park, Soo Mi Kim
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/21/11486
_version_ 1797512525675233280
author Ruo Yu Meng
Hua Jin
Thi Van Nguyen
Ok-Hee Chai
Byung-Hyun Park
Soo Mi Kim
author_facet Ruo Yu Meng
Hua Jin
Thi Van Nguyen
Ok-Hee Chai
Byung-Hyun Park
Soo Mi Kim
author_sort Ruo Yu Meng
collection DOAJ
description Ursolic acid (UA), a pentacyclic triterpenoid extracted from various plants, inhibits cell growth, metastasis, and tumorigenesis in various cancers. Chemotherapy resistance and the side effects of paclitaxel (PTX), a traditional chemotherapy reagent, have limited the curative effect of PTX in esophageal cancer. In this study, we investigate whether UA promotes the anti-tumor effect of PTX and explore the underlying mechanism of their combined effect in esophageal squamous cell carcinoma (ESCC). Combination treatment with UA and PTX inhibited cell proliferation and cell growth more effectively than either treatment alone by inducing more significant apoptosis, as indicated by increased sub-G1 phase distribution and protein levels of cleaved-PARP and cleaved caspase-9. Similar to the cell growth suppressive effect, the combination of UA and PTX significantly inhibited cell migration by targeting uPA, MMP-9, and E-cadherin in ESCC cells. In addition, combination treatment with UA and PTX significantly activated p-GSK-3β and suppressed the activation of Akt and FOXM1 in ESCC cells. Those effects were enhanced by the Akt inhibitor LY2940002 and inverted by the Akt agonist SC79. In an in vivo evaluation of a murine xenograft model of esophageal cancer, combination treatment with UA and PTX suppressed tumor growth significantly better than UA or PTX treatment alone. Thus, UA effectively potentiates the anti-tumor efficacy of PTX by targeting the Akt/FOXM1 cascade since combination treatment shows significantly more anti-tumor potential than PTX alone both in vitro and in vivo. Combination treatment with UA and PTX could be a new strategy for curing esophageal cancer patients.
first_indexed 2024-03-10T06:02:03Z
format Article
id doaj.art-d28bd70cecc64f66bf6cb2ef10fc4235
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T06:02:03Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-d28bd70cecc64f66bf6cb2ef10fc42352023-11-22T20:52:56ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-10-0122211148610.3390/ijms222111486Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling CascadeRuo Yu Meng0Hua Jin1Thi Van Nguyen2Ok-Hee Chai3Byung-Hyun Park4Soo Mi Kim5Department of Physiology, Institute for Medical Sciences, Jeonbuk National University Medical School, Jeonju 54907, KoreaSchool of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, ChinaDepartment of Anatomy, Institute for Medical Sciences, Jeonbuk National University Medical School, Jeonju 54907, KoreaDepartment of Anatomy, Institute for Medical Sciences, Jeonbuk National University Medical School, Jeonju 54907, KoreaDepartment of Biochemistry, Jeonbuk National University Medical School, Jeonju 54907, KoreaDepartment of Physiology, Institute for Medical Sciences, Jeonbuk National University Medical School, Jeonju 54907, KoreaUrsolic acid (UA), a pentacyclic triterpenoid extracted from various plants, inhibits cell growth, metastasis, and tumorigenesis in various cancers. Chemotherapy resistance and the side effects of paclitaxel (PTX), a traditional chemotherapy reagent, have limited the curative effect of PTX in esophageal cancer. In this study, we investigate whether UA promotes the anti-tumor effect of PTX and explore the underlying mechanism of their combined effect in esophageal squamous cell carcinoma (ESCC). Combination treatment with UA and PTX inhibited cell proliferation and cell growth more effectively than either treatment alone by inducing more significant apoptosis, as indicated by increased sub-G1 phase distribution and protein levels of cleaved-PARP and cleaved caspase-9. Similar to the cell growth suppressive effect, the combination of UA and PTX significantly inhibited cell migration by targeting uPA, MMP-9, and E-cadherin in ESCC cells. In addition, combination treatment with UA and PTX significantly activated p-GSK-3β and suppressed the activation of Akt and FOXM1 in ESCC cells. Those effects were enhanced by the Akt inhibitor LY2940002 and inverted by the Akt agonist SC79. In an in vivo evaluation of a murine xenograft model of esophageal cancer, combination treatment with UA and PTX suppressed tumor growth significantly better than UA or PTX treatment alone. Thus, UA effectively potentiates the anti-tumor efficacy of PTX by targeting the Akt/FOXM1 cascade since combination treatment shows significantly more anti-tumor potential than PTX alone both in vitro and in vivo. Combination treatment with UA and PTX could be a new strategy for curing esophageal cancer patients.https://www.mdpi.com/1422-0067/22/21/11486ursolic acidesophageal squamous cell carcinomaapoptosisFOXM1Akt
spellingShingle Ruo Yu Meng
Hua Jin
Thi Van Nguyen
Ok-Hee Chai
Byung-Hyun Park
Soo Mi Kim
Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade
International Journal of Molecular Sciences
ursolic acid
esophageal squamous cell carcinoma
apoptosis
FOXM1
Akt
title Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade
title_full Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade
title_fullStr Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade
title_full_unstemmed Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade
title_short Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade
title_sort ursolic acid accelerates paclitaxel induced cell death in esophageal cancer cells by suppressing akt foxm1 signaling cascade
topic ursolic acid
esophageal squamous cell carcinoma
apoptosis
FOXM1
Akt
url https://www.mdpi.com/1422-0067/22/21/11486
work_keys_str_mv AT ruoyumeng ursolicacidacceleratespaclitaxelinducedcelldeathinesophagealcancercellsbysuppressingaktfoxm1signalingcascade
AT huajin ursolicacidacceleratespaclitaxelinducedcelldeathinesophagealcancercellsbysuppressingaktfoxm1signalingcascade
AT thivannguyen ursolicacidacceleratespaclitaxelinducedcelldeathinesophagealcancercellsbysuppressingaktfoxm1signalingcascade
AT okheechai ursolicacidacceleratespaclitaxelinducedcelldeathinesophagealcancercellsbysuppressingaktfoxm1signalingcascade
AT byunghyunpark ursolicacidacceleratespaclitaxelinducedcelldeathinesophagealcancercellsbysuppressingaktfoxm1signalingcascade
AT soomikim ursolicacidacceleratespaclitaxelinducedcelldeathinesophagealcancercellsbysuppressingaktfoxm1signalingcascade